Keep pulling the thread on Bloomberg Businessweek Weekend.
Apple's hardware chief, John Ternus, is set to become the company's new CEO in September.
Tim Cook will transition to the role of executive chairman at Apple after John Ternus becomes CEO.
Tesla plans to increase its capital expenditures to over $25 billion in 2026 to fund its expansion into AI and robotics.
A White House executive order directs the FDA to issue expedited review vouchers for psychedelic drugs that have received a "breakthrough designation."
Shares of Compass Pathways surged 53% following a White House executive order to fast-track research into psychedelic treatments.
In one of its late-stage studies, Compass Pathways found that 25% of patients experienced a significant reduction in depression symptoms after a single administration of its COM360 psilocybin treatment.
In a second late-stage study by Compass Pathways, 40% of patients showed a meaningful reduction in depression symptoms after treatment with COM360.
Mark Gurman predicts that under John Ternus's leadership, AI will be integrated throughout Apple's products and operations at a faster pace.
Apple's revenue for its most recent holiday quarter exceeded $140 billion, marking its strongest ever.
The White House executive order on psychedelics is expected to shorten the FDA review time for designated drugs to one to two months, down from the current six to ten months.
Compass Pathways is studying its synthetic psilocybin, COM360, for treatment-resistant depression, which affects 4 million people in the U.S., and for PTSD, which affects over 13 million.
Compass Pathways intends to complete its regulatory submission to the FDA for its COM360 treatment later this year.